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Abstract
Objectives: Health care workers, including dentists, are at the front line for acquiring blood-borne virus infections. This study 
aimed to investigate the prevalence of hepatitis B, hepatitis C and human immunodeficiency viruses among Iranian dentists. 
Material and Methods: The survey included 1628 dental health care workers who attended the 51st annual Congress of the Ira-
nian Dental Association. Data on the risk of blood-borne virus transmission during health care and infection control practices 
were gathered from self-administered questionnaires. Sera were screened serologically by enzyme-linked immunosorbent as-
say (ELISA). The positive samples were examined by polymerase chain reaction (PRC) followed by direct sequencing. Results: 
Six (0.36%) and 81 (5.0%) were positive for hepatitis B surface antigen (HBsAg) and (anti-hepatitis B virus core antigen (anti-
HBc), respectively. Only 1 (0.061%) was positive for anti-hepatitis C virus (anti-HCV). No case was positive for anti-human im-
munodeficiency virus (anti-HIV). One case was diagnosed as being occult hepatitis B virus (HBV) infection. One thousand five 
hundred thirty-five (94.3%) of participants had received at least 1 dose of HBV vaccine. One thousand three hundred fifty-nine 
(88.5%) contained hepatitis B surface antibody (anti-HBs) > 10 IU/ml, of whom 55 (4.0%) were anti-HBc positive, suggesting 
that they had been infected with HBV in the past. Anti-HBc positive cases had past histories of hepatitis, either their own or their 
spouses’. Individuals with inadequate anti-HBs levels (< 10 IU/ml) were significantly more prevalent among anti-HBc positive 
cases (p < 0.001). Conclusions: The prevalence of blood-borne viruses among dental HCWs found in this study was lower than 
past reports from Iranian dentists and general population. The implementation of HBV vaccination together with improvement 
in infection control procedures has reduced the potential for risk infection among Iranian dentists.
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Italy [19], 1.2% in United Kingdom (UK) [20], 0.7–2% 
in USA [4], and 3.3% in Canada [9]. Finally, the preva-
lence for HIV has been considerably lower in dental set-
tings: 0.02–0.3% (UK) [21] and 0.33% (Canada) [9].
The aims of the present study were to investigate the sero-
prevalence and occupational factors and other associates 
of BBV sero-posivity among Iranian dentists.
MATERIAL AND METHODS
Participants
The study was a nonrandomized, cross-sectional survey 
of dental health care workers attending the 51st annual 
Congress of the Iranian Dental Association (Tehran, Iran) 
held on 10–13 May 2011. A total of 1628 participants were 
recruited. The inclusion criteria were: being involved in 
dental experience (regardless of job details), and willing-
ness to give blood samples. For dental students, the du-
ration of dental practice was excluded from the analysis. 
Informed consent was obtained from all the enrolled par-
ticipants, and a questionnaire was used to collect data. 
Items of inquiry included gender, age, occupational infor-
mation, details of using protective barriers and history of 
risk factors related to blood-borne transmission. The posi-
tive BBV cases were referred to Tehran Hepatitis Network 
for clinical following up. Due to the large amount of data, 
the detail of HBV vaccination status of participants has 
been published elsewhere [22].
Serology
Viral markers of hepatitis B virus were measured by 
enzyme-linked immunosorbent assay (ELISA) including 
HBsAg, anti-HBs and anti-HBc (HBcAb 1 step, MBS. SRL. 
Medical Biological Service, Italy). Antibodies to HCV 
an HIV were detected by ELISA using Anti-HCV 3.0 ELI-
SA Kit and Anti-HIV Plus ELISA Kit (MBS SRL Medi-
cal Biological Services, Italy).
All HBsAg, anti-HCV and anti-HIV reactive samples were 
rechecked by other ELISA kits from different companies.
INTRODUCTION
Health care workers (HCWs) are at the front line for ac-
quiring blood-borne virus (BBV: hepatitis B virus (HBV), 
hepatitis C virus (HCV) and human immunodeficiency 
virus (HIV)) infections. Among the HCWs, dentists are 
the most highly exposed group and many dentists expe-
rience a needle stick or puncture of finger skin very of-
ten [1,2,3]. Due to the nature of invasive medical instru-
ments used in dentistry, the transmission of blood-borne 
viruses in dental offices is a potential hazard to both 
patients and dental staff. Worldwide, dental health care 
workers experience higher chance of HBV infection than 
of other blood-borne viruses like HCV and HIV; and HBV 
incidences increase with years of clinical experience as 
a dentist [4,5]. Moreover, a higher prevalence of HBV 
infection especially among surgical specialties (oral and 
maxillofacial surgeons and periodontists) compared to 
the general population has been reported [6,7].
Owing to the implementation of HBV vaccine in the im-
munization program for infants and high risk groups (in-
cluding HCWs), HBV infection rates have been decreased 
dramatically. However, past (anti-hepatitis B virus core an-
tigen (anti-HBc) positivity) or present (hepatitis B surface 
antigen (HBsAg) positivity) HBV infection rates in dentists 
are usually higher than in the general population, regard-
less of HBV endemicity in the area [8]. Hepatitis B surface 
antigen (HBsAg) prevalence among dentists has been re-
ported to be 0.6% in Canada [9], 2.4% in Malaysia [10] 
and 13% in Korea [11]. The rate of anti-HBc prevalence 
is 10.8% in Brazil [12], 9.6% in Argentine [13], 7.8% in 
the USA [4], 12% in Japan [14] and 7% in Germany [15]. 
Therefore, dental care workers should be advised to re-
ceive a hepatitis B vaccine and it should be confirmed if 
they have acquired immunity to HBV [4,5,15]. 
Regarding other BBVs, lower risks of transmission be-
tween dental HCWs are associated with HCV includ-
ing: 0.0% in Japan [14], 0.5% in Germany [15], 0.4–
0.9% in Brazil [16,17], 0.33% in Israel [18], 0.4% in 
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and compared with the Chi2 or Fisher’s exact test. Ninety-
five percent confidence intervals for the point estimates 
were provided. P value less than 0.05 was considered sig-
nificant. Data were analyzed with SPSS version 18.
RESULTS
The basic characteristics of dental health care work-
ers are shown in Table 1. The mean age of participant 
was 40.4±11.1 years (from 19 to 75). From the total 
of 1628 participants, 1070 (65.7%) and 558 (34.3%) were 
male and female, respectively. The mean duration for 
dental practice was 15.5±9.3 years (from 0 to 55 years), 
with exception of dental students.
Blood-borne viruses (BBV) prevalence
Overall, among 1628 dental care workers, 7 (0.42%) 
were positive for HBsAg (all were positive also for anti-
HBc) and 81 (5.0%) were anti-HBc positive. Only 1 per-
son (0.061%) was positive for anti-HCV. No case was 
positive for anti-HIV (Table 1).
Of 81 anti-HBc positive individuals, 66 (81.4%) had 
a history of vaccination (Table 1); 55 (83.3%) had pro-
tective levels of anti-HBs (≥ 10 IU/ml), and 11 (16.7%) 
had inadequate anti-HBs levels (< 10 IU/ml). Neverthe-
less, 13 (16.5%) of anti-HBc positive dentists did not re-
ceive vaccine, 7 had ≥ 10 IU of anti-HBs and 6 had in-
adequate levels (< 10 IU/ml) of whom 2 were positive 
for HBsAg (Table 1). A history of HBV vaccination was 
missing for 2 anti-HBc-positive individuals. More details 
of HBV vaccination are shown in Table 1.
Fifty-two serodiscordant cases had enough sera for fur-
ther molecular studies. Real-time PCR was carried out 
on all these samples. One case was diagnosed as being 
occult HBV infection (HBsAg negative, HBV DNA posi-
tive with titer of 1950 copy/ml). He was HBeAg negative, 
anti-HBe positive. In mutational analysis, no mutation was 
found over the entire surface protein (results not shown). 
Hepatitis B surface antigen positive cases had HBV DNA 
DNA extraction, polymerase chain reaction (PCR) 
and DNA sequencing
When the serum was positive for either HBsAg or anti-
HBc, HBV DNA levels were analyzed using real-time PCR. 
Subsequently, surface standard PCR and sequencing for 
surface gene were carried out. Hepatitis B virus (HBV) 
DNA was extracted from a 200 μl of aliquot of serum us-
ing Qiagen Mini Blood Kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s instruction. At the final 
step, DNA was eluted using 100 μl of elution buffer, stored 
in –20°C. Real-time PCR was applied for HBV serodis-
cordant sera using Fast-diagnostics kits (Luxembourg) ac-
cording to manufacturer’s instructions. Polymerase chain 
reaction (PCR) was carried out in 100 μl of a mixture con-
taining 5 μl of the extracted DNA to amplify the complete 
surface gene using S1, S2, S6 and S7 primers as described 
previously [23]. Direct sequencing of surface gene was car-
ried out (Genetic Analyzer ABI- 3130 DNA Sequencer, 
Fostercity, CA, USA) using 2 pmol of appropriate prim-
ers: S6C and S7D for surface gene. The electrophero-
grams were examined visually using Chromas program. 
Sequences of surface gene were aligned using the BioEdit 
Package version 7.0.9.
Data analysis
The results on BBV status were compared between sub-
jects on the basis of: demographic features, HBV vaccina-
tion status, BBV transmission risk factors, using routine 
protective tools. Finally, the study groups were compared 
according to the results of BBV infection into positive 
and negative groups and the variables were compared 
as a whole.
Statistical study
The descriptive statistics was calculated. Continuous 
variables were presented as means and standard devia-
tions and compared using Student’s t test. Categorical 
variables were demonstrated as numbers and percentages 
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levels (median (Me): 1.8×105 ranging between 1.3×104 
and 3.44×105 copy/ml). No other cases were positive by 
real-time PCR. Twelve cases were isolated anti-HBc. 
Twenty-six of cases showed adequate levels of anti-HBs in 
the absence of previous vaccination. Hence, they had a his-
tory of resolved HBV infection. Seven cases were positive 
for both anti-HBc and anti-HBs antibodies, suggesting 
a typical HBV resolved infection.
Status of HBV vaccination
From total vaccinated 1535 individuals, 176 (11.5%) had 
levels of anti-HBs < 10 IU/ml and 1359 (88.5%) had anti-
HBs > 10 IU/ml, regardless of the number of doses and 
time after the last dose or time intervals between doses 
(Table 1) [22]. Among the latter group, 55 were anti-HBc 
positive with no apparent clinical history of HBV-related 
liver diseases, suggesting that they had been infected 
with HBV in the past. Thirty-three individuals attained ad-
equate levels of anti-HBs in the absence of previous HBV 
vaccination (Table 1), indicating acquisition of previous 
infection at some time in the past, resulting in the natural 
immunity.
Distribution of BBV among dental health care workers
Seventy of 81 (85.2%) anti-HBc-positive and all HBsAg 
positive (100%) cases were general practitioners. None of 
general dental practitioners had evidence of HCV infec-
tion (Table 1). Seven of 119 (5.8%, 95% CI: 2.6–11.8%) 
specialists, 1/37 (2.7%, 95% CI: 0.5–13.6%) dental assis-
tants and 3/155 dental students (1.9%, 95% CI: 0.7–5.5%) 
were anti-HBc positive (results not shown). One of spe-
cialist group was positive for anti-HCV.
Risk factors
To determine possible risk factors for BBV acquisi-
tion, 1084/1592 (68.1%) were reported to have at 
least 1 history of needle stick and other sharp-tool in-
juries (results not shown). This prevalence was higher, 
Table 1. Basic characteristics of dental participants 
Variable Participants (N = 1 628)
Age [years] (M±SD) 40.40±11.07
Gender [n (%)]
male 1 070 (65.72)
female 558 (34.27)
HBV vaccination [n (%)]
no 60 (3.68)
yes 1 535 (94.28)
unknown 33 (2.02)
Marriage status [n (%)]
single 396 (24.30)
married 1 207 (74.00)
Anti-HBs status [n (%)]
< 10 IU/ml 176 (11.46)
≥ 10 IU/ml 1 359 (88.53)
HBcAb titer [n (%)]
negative 1 547 (95.02)
positive 81 (4.97)
HBsAg [n (%)]
negative 1 621 (99.57)
positive 7 (0.42)
Anti-HCV Ab [n (%)]
negative 1 627 (99.94)
positive 1 (0.06)
Anti-HIV Ab [n (%)]
negative 1 628 (100)
positive 0 (0.00)
Anti-HBc/HBsAg state [n (%)]




M – mean; SD – standard deviation; HBV – hepatitis B virus; anti-
HBs – hepatitis B surface antibody; HBcAb – hepatitis B core anti-
body; HBsAg – hepatitis B surface antigen; anti-HCV Ab – anti-hepa-
titis C virus antibodies; anti-HIV Ab – anti-human immunodeficiency 
virus; anti-HBc – anti-hepatitis B virus core antigen.
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use new disposables for every new patients. The frequen-
cies of using such tools were lower for those who were pos-
itive for anti-HBc, but this association was not significant 
(97.5 vs. 97.8, p = 0.70) (Table 2). However, the odds of 
previous or current HBV infection for dentists who regu-
larly wore shield were higher than of those who used them 
irregularly or not at all.
Anti-HBc positive vs. anti-HBc negative 
group comparison
Finally, the 81 dentists with serological evidence 
of HBV infection (anti-HBc/HBsAg) were compared to 
the 1547 without either. In univariate analysis, the follow-
ing variables had significant effects on being anti-HBc pos-
itive (Table 2). The mean age of anti-HBc positive group 
was higher than anti-HBc negative group (p < 0.001). 
A majority of anti-HBc positive individuals were of 
male gender (p = 0.04%) (Table 2). A significant 
although not significantly, than for those who were nega-
tive for any BBV infection (76.2% vs. 67.6%, p = 0.11) (re-
sults not shown). Sixty-seven of 1605 (4.2%) of cases had 
a history of sharp trauma, of whom only 1 (1.5%) was posi-
tive for anti-HBc. Ninety of 1604 (5.6%) of participants 
had a history of transfusion, of those 10 (11.1%) were pos-
itive for anti-HBc (Table 2). The anti-HCV positive case 
had 2 episodes of needle-stick injury.
All HBsAg positive cases were general practitioners and 
of male gender and they were married. All showed anti-
HBs < 10 IU/ml, however, they had been vaccinated. They 
have been working as dentists for at least 15 years. All had 
a positive history for needle stick injury. No other risk 
factor determinants for HBV infection were found.
Protective barriers
Regarding using routine protective tools as 
a whole, 1542 out of 1575 (97.9%) were reported to 







(N = 1 547)
Age [years] (M±SD) 46.8±12.2 40.1±10.9 < 0.001
Duration of dental practice [years] (M±SD) 20.1±11.5 15.2±9.1 0.001
Gender (male) [n (%)] 62 (76.5) 1 006 (34.8) 0.04
Marital status (being married) [n (%)] 67 (83.7) 1 136 (74.8) 0.07
Vaccination [n (%)] 66 (81.4) 1 468 (96.9) < 0.001
Incomplete anti-HBV immunity [n (%)] 18 (22.2) 190 (12.3) 0.009
History of needle stick [n (%)] 60 (75.9) 1 020 (67.5) 0.12
History of liver diseases [n (%)] 11 (13.6) 105 (6.8) 0.02
History of blood transfusion [n (%)] 10 (12.5) 80 (5.2) 0.01
Using gloves for each patient [n (%)] 78 (97.5) 1 469 (95.0) 0.70
Using mask for each patient [n (%)] 78 (96.3) 1 444 (96.0) 1.00
Using glasses for each patient [n (%)] 54 (68.3) 1 128 (95.4) 0.09
Using shield for each patient [n (%)] 19 (25.0) 547 (37.9) 0.02
Abbreviations as in Table 1.
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on HBV endorsed by World Health Organization (WHO) 
together with HBV vaccination national programs among 
dentists, recent data show that this prevalence is equal 
or even lower in dentists than that of general popula-
tion [12,38]. In Iran, it is estimated that over 35% of 
the general population have been exposed to HBV and 
approximately 2.5% are chronic carriers [39]. In the pres-
ent study, only 0.36% and 4.5% of individuals were posi-
tive for HBsAg and anti-HBc, respectively. On the other 
hand, previous studies on Iranian dental health care work-
ers showed a prevalence of 1.1% and 7–14.7% for HBsAg 
and anti-HBc positivity, respectively [40–42]. However, 
sample sizes in those studies were small as well as they 
were encumbered with sample selection bias, because 
the participants were recruited from single provinces in-
stead of the general dentistry community. The present 
study confirms that application of HBV vaccine together 
with protective tools has decreased the overall HBV 
infection in this high-risk group.
WHO has declared that dentists are at greater risk of ac-
quiring HCV. Despite this, a number of studies have 
shown that the prevalence of HCV infection in this group 
is similar (1.2%) [19] or even lower (0.0%) [14] than that 
of the general population [43]. Interestingly, only 1 out 
of 1628 (0.06%) of dental care workers in our study 
was HCV-positive. Similarly, 1 Iranian study on dental 
workers showed a prevalence of 0% for HCV [40]. 
Moreover, in a Brazilian study, the seroprevalence of HCV 
was 0.9% among a calculated sample of 1302 dentists test-
ed, which was lower than the 1.42% prevalence of HCV 
reported for the general population in the same area [16]. 
Collectively, other similar results for HCV prevalence in 
dental HCWs [14] suggest that dentists have a lower risk 
of HCV infection caused by occupational accidents than 
expected by the WHO [43]. As the serum viral concentra-
tion and exposure dose are critical factors for the trans-
mission of blood-borne pathogens, the low prevalence 
of HCV among dentists may be explained by the relatively 
proportion of anti-HBc positive individuals were mar-
ried (p = 0.07). Also, the duration of dental practice was 
longer in the anti-HBc positive than the anti-HBc negative 
group (20.1±11.5 vs. 15.2±9.1, p < 0.001) (Table 2). Anti-
HBc positive cases had past histories of hepatitis either 
in their own or her/his spouse (for both p < 0.001). Sixty-
six (83.5%) of anti-HBc individuals were vaccinated. Vac-
cination history of these 2 groups showed that anti-HBs 
levels below 10 IU/ml were more prevalent among anti-
HBc positive cases (p < 0.06) (Table 2).
DISCUSSION
Due to the fact that dental health proceedures involve 
aerosol-forming equipment and sharp devices [24,25], 
there has long been a great concern about transmission 
of blood-borne pathogens in dentistry [26,27]. The trans-
mission of blood-borne viruses in dental offices is a po-
tential hazard to patients [28]; and as dentists and dental 
staff during their routine practice use sharp instruments in 
an environment contaminated with saliva and blood, they 
appear particularly prone to these blood-borne infections. 
Despite of no evidence for non-parenteral (enteral/respi-
ratory) transmission of BBV, there have been controver-
sies about the oral transmission efficiency for BBVs [29–
31], and thus, virus transmission via saliva may be possible, 
probably due to the contamination of saliva with blood. 
Although the probability of infections due to contaminat-
ed needle sticks are lower for HCV and HIV compared 
to HBV [32,33], the rate of contracting HBV infection 
through HBV-contaminated needles is as high as 12% [34] 
to 60% (in unvaccinated individuals) [14,35].
The risk of occupational blood-borne infections by den-
tal practitioners is well recognized in the case of HBV. 
Numerous reports are accessible indicating that before 
the availability of vaccine against HBV in the 80s, the se-
roprevalence of HBV was higher among dentists than in 
the general population [36,37]. However, after the imple-
mentation of Expanded Program on Immunization (EPI) 
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p = 0.70), however, odds of such markers were higher 
for dentists who regularly wore shield than of those who 
used them irregularly or did not use them at all.
The present study has some limitations. Cross-sectional 
studies are performed either over a short period or at 
a single point in time. Thus, causal relationship should not 
be considered for associations identified in these studies. 
Also, due to the fact that the participants’ responses were 
self-reported, generalizations must be considered with 
caution. Moreover, the probability of information bias 
could be involved, because some volunteers may prac-
tice habits or activities different from their self-reported 
behavior. Therefore, our findings may not represent 
the whole population of Iranian dentists. Our sample size, 
however, the largest among Iranian dental worker sur-
veys studies, has shed important light on the prevalence 
of BBV between Iranian dentists.
CONCLUSIONS
In conclusion, despite that prevalence of HBV among 
dental HCWs found in this study was lower than in other 
reports from Iran and also lower than that in the Iranian 
general population, due to the invasive nature of dental 
practice, permanent vigilance and educational programs 
addressing BBV infection among dentists are necessary. 
Guidelines need to be developed to ensure that the en-
tire dental team is vaccinated against HBV. To reduce risk 
of HCV and HIV infections (as no vaccine is available yet 
for both), educational interventions are required to im-
prove compliance with universal precautions, the use of 
barriers, puncture-proof containers for sharps disposal, 
and post-exposure protocols.
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